Showing 1 - 7 results of 7 for search 'Ronald D Perrone', 查询时间: 0.03s Refine Results
  1. 1
    Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry

    Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry 由 Elise Hoover, Vanessa Holliday, Nicole Merullo, Dorothee Oberdhan, Ronald D. Perrone, Chris Rusconi, Meyeon Park, Milind A. Phadnis, Nadeesha Thewarapperuma, Neera K. Dahl

    出版 2024-05-01
    获取全文
    文件
  2. 2
    Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

    Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease 由 Ronald D. Perrone, Mohamad-Samer Mouksassi, Klaus Romero, Frank S. Czerwiec, Arlene B. Chapman, Berenice Y. Gitomer, Vicente E. Torres, Dana C. Miskulin, Steve Broadbent, Jean F. Marier

    出版 2017-05-01
    获取全文
    文件
  3. 3
    The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression

    The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression 由 Myrte K. Neijenhuis, Wietske Kievit, Ronald D. Perrone, Jeff A. Sloan, Patricia Erwin, Mohammad Hassan Murad, Tom J. G. Gevers, Marie C. Hogan, Joost P. H. Drenth

    出版 2017-05-01
    获取全文
    文件
  4. 4
    Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial

    Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial 由 Maria V. Irazabal, Jaime D. Blais, Ronald D. Perrone, Ron T. Gansevoort, Arlene B. Chapman, Olivier Devuyst, Eiji Higashihara, Peter C. Harris, Wen Zhou, John Ouyang, Frank S. Czerwiec, Vicente E. Torres

    出版 2016-11-01
    获取全文
    文件
  5. 5
    OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD

    OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD 由 Ronald D. Perrone, Dorothee Oberdhan, John Ouyang, Daniel G. Bichet, Klemens Budde, Arlene B. Chapman, Berenice Y. Gitomer, Shigeo Horie, Albert C.M. Ong, Vicente E. Torres, A. Neil Turner, Holly Krasa

    出版 2023-05-01
    获取全文
    文件
  6. 6
    The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKDPlain-Language Summary

    The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKDPlain-Language Sum... 由 Ronald D. Perrone, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B. Chapman, Shigeo Horie, Bertrand Knebelmann, Michal Mrug, Albert C.M. Ong, York P.C. Pei, Vicente E. Torres, Vijay Modur, Ronald T. Gansevoort

    出版 2022-10-01
    获取全文
    文件
  7. 7
    Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.

    Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review. 由 Patrizia Natale, Elyssa Hannan, Bénédicte Sautenet, Angela Ju, Ronald D Perrone, Eva Burnette, Niek Casteleijn, Arlene Chapman, Sarah Eastty, Ron Gansevoort, Marie Hogan, Shigeo Horie, Bertrand Knebelmann, Richard Lee, Reem A Mustafa, Richard Sandford, Amanda Baumgart, Allison Tong, Giovanni F M Strippoli, Jonathan C Craig, Gopala K Rangan, Yeoungjee Cho

    出版 2021-01-01
    获取全文
    文件

检索工具: